U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Did You Know...

...that Kleenex tissue was originally designed to be a gas mask filter? It was developed at the beginning of World War I to replace cotton, which was then in short supply as a surgical dressing.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 514/670 - Monoether


Subclass of Class 514 - Drug, bio-affecting and body treating compositions
Definition: Subject matter wherein the compound contains only one C-O-C
No. of patents: 35
Last issue date: 12/15/2009


NumberTitleIssue Date
7632869Antimicrobial compositions and uses thereof
The use of compositions containing one or more ether amine antimicrobial agents and/or ether amine derivative antimicrobial agents in an amount effective to disinfect and/or preserve medical devices is described. Solutions containing one or more ether amine antimicr...
12/15/2009
7307071RAF-MEK-ERK pathway inhibitors to treat cancer
Materials and methods for treating certain cancers are described, preferably cancers that result from the up-regulation of the RAF-MEK-ERK pathway, and more preferably chronic myelogenous leukemia, and which cancer is preferably resistant to the inhibition of the Bc...
12/11/2007
7250157Dermatological compositions and methods
Disclosed are methods and compositions for regulating the melanin content of mammalian melanocytes; regulating pigmentation in mammalian skin, hair, wool or fur; treating or preventing various skin and proliferative disorders; by administration of various compounds,...
07/31/2007
7145039Transfection reagents
Disclosed are compounds capable of facilitating transport of biologically active agents or substances into cells having the general structure: wherein Q is selected from the gro...
12/05/2006
7060731Use of amines
This application relates to the use of certain amines of formula (I) for combatting and preventing systemic and local complement activation, and in particular to the use of meglumine and derivatives and optionall...
06/13/2006
6964984Preventing desensitization of receptors
Desensitization of receptors that control disease is prevented by inhibiting G-protein receptor kinases. This has applicability, e.g., for patients with heart failure or on a left ventricular heart device or a heart pump after surgery or about to undergo surgery and...
11/15/2005
6964782Stable hydrogen peroxide compositions, products and methods of use
Disclosed are several preferred embodiments of hydrogen peroxide which are packaged with ease of use and extended shelf-life in mind. The embodiments include foam, mist, gel, and disposable towelette forms of H2O2. Optional ingredients of topic...
11/15/2005
6955804Dermatological compositions and methods
Disclosed are methods and compositions for regulating the melanin content of mammalian melanocytes; regulating pigmentation in mammalian skin, hair, wool or fur; treating or preventing various skin and proliferative disorders; by administration of various compounds,...
10/18/2005
6932985Azide method and composition for controlling deleterious organisms
Disclosed is both a method and composition for controlling deleterious organisms, such as insects, nematodes and weeds by applying a compound comprised of a liquid medium comprising azide and amine. The azide can be selected from the group consisting of sodium azide...
08/23/2005
6900244Anilino liver X-receptor modulators
The present invention is directed to selective LXR modulators, small molecule compounds corresponding to Formula I and is further directed to a process of treating a condition in a mammal that is modulated by LXR using a therapeutically effective dose of a compound ...
05/31/2005
6623724Dermatological compositions and methods
Disclosed are methods and compositions for regulating the melanin content of mammalian melanocytes; regulating pigmentation in mammalian skin, hair, wool or fur; treating or preventing various skin and proliferative disorders; by administration of various...
09/23/2003
6566397Acyclic isoprenoid ether derivatives as chemotherapeutics
A method of and compositions for suppressing the growth of tumor cells in a patient are disclosed. In one embodiment, the method comprises treating the patient with an effective amount of an isoprenoid ether-linked compound, wherein the isoprenoid ether-l...
05/20/2003
6541038Method for treating wood with a metal-containing treating agent and wood treated thereby
A method for treating wood, characterized by impregnating wood with a metal-containing treating agent containing lignin and/or lignin derivatives and a metal, a metal compound, and/or a metal ion and oxidizing and/or macromolecularizing of the lignin and/...
04/01/2003
6376547Tuberculocidal disinfectant
The invention relates to the use of an N,N'-substituted glycine or of an N,N'-substituted derivative of glycine (a) of the general formula I ##STR1## in which R1 is hydrogen or a straight-chain or branched, saturated or unsaturated alkyl, alkar...
04/23/2002
6274630Method of inhibiting biosynthesis of EIf5A
A method and pharmaceutical composition for inhibiting or preventing the intracellular biosynthesis of EIf5A by the administration to a human or non-human mammal in need thereof an amount of a polyamine analogue or salt thereof sufficient to deplete the s...
08/14/2001
6265412Minoxidil compositions for external use
There is provided a composition for external use with a reduced skin irritation comprising minoxidil and 0.01 to 2 parts by weight of at least one antihistaminic agent selected from the group consisting of chlorphenylamine maleate, diphenylimidazole, diph...
07/24/2001
6245817NPY5 receptor antagonists and methods for using same
଱-alkoxy and ଱-thioalkoxyamide compositions and methods of administering the compositions to mammals to treat disorders such as obesity that are mediated by NPY and especially those mediated by NPY via the Y5 receptor....
06/12/2001
6190733Alkylated aminoether surfactants
This invention provides water-based compositions, particularly coating, ink, and agricultural compositions, manifesting reduced equilibrium and dynamic surface tension by the incorporation of a surface tension reducing amount of certain alkylated aminoeth...
02/20/2001
6103768Fatty acid based compositions and methods for the control of plant infections and pests
The invention described here concerns the unique utility of fatty acids and their derivatives to eradicate existing fungal and bacterial infections in plants. Also, described herein are combination treatments whereby fatty acids are used to enhance or aug...
08/15/2000
6051056Alkylated aminoether surfactants
This invention provides water-based compositions, particularly coating, ink, and agricultural compositions, manifesting reduced equilibrium and dynamic surface tension by the incorporation of a surface tension reducing amount of certain alkylated aminoeth...
04/18/2000
6048900Amide derivatives and methods for using the same as selective neuropeptide Y receptor antagonists
Amide derivatives and methods of administering the compositions to mammals to treat disorders such as obesity that are mediated by NPY and especially those mediated by NPY via the Y5 receptor....
04/11/2000
5973000Hair revitalization tonic composition containing a lipid derivative and use thereof
The invention relates to a hair revitalizing tonic composition containing, as an active ingredient, at least one lipid derivative of the general formula ##STR1## wherein R1, R2, R3, R4 and Y are as defined ...
10/26/1999
5854178Bioactive compounds
Novel bioactive compounds which when applied to plants in bioregulatory amounts, enhance plant development responses, resulting in enhanced plant properties such as increased total biomass, increased yield, and increased plant quality. Some of the compoun...
12/29/1998
5723497Amine derivative and dermatologic preparation containing the same
The present invention relates to an amine derivative represented by the following general formula (I) or (II): ##STR1## wherein R1 means a heteroatom-containing C1 -C40 hydrocarbon group which may have a ring structur...
03/03/1998
5622995Methods for control and mitigation of molluscs
A method is provided for controlling the proliferation of molluscs in target habitat by applying to the habitat a compound or mixture of compounds which are amines, ethoxylated amines, quaternary amines, ethoxylated quaternary amines and cyclic amines....
04/22/1997
5182297Inhibitors of lysyl oxidase
This invention relates to certain inhibitors of lysyl oxidase and their use in the treatment of diseases and conditions associated with the abnormal deposition of collagen....
01/26/1993
5021456Inhibitors of lysyl oxidase
This invention relates to certain inhibitors of lysyl oxidase and their use in the treatment of diseases and conditions associated with the abnormal deposition of collagen....
06/04/1991
4943593Inhibitors of lysyl oxidase
This invention relates to certain inhibitors of lysyl oxidase and their use in the treatment of diseases and conditions associated with the abnormal deposition of collagen....
07/24/1990
4923887Liquid formulations of 1,2-benzisothiazolin-3-one, their preparation and their use
Antimicrobially active liquid composition formulation which comprises 1,2-benzisothiazolin-3-one and at least one amine-oxyethylate of the formula ##STR1## wherein R is alkyl or alkenyl each having 2 to 22 carbon atoms and the sum of m and n is ...
05/08/1990
4874786Cyanoacetamido-derivatives having a fungicidal activity
A method of fighting fungus infections by using compounds having the formula: ##STR1## wherein: R is H, a C1 -C4 alkyl, an alkenyl, or an alkynyl radical; n is 1 or 2; A represents a C1 -C6 alkylene bridge,...
10/17/1989
4314965Sterilization process using a heat effect additive
A process of sterilization or decontamination of apparatus, characterized in that an aqueous solution containing at least 0.01% of a compound of the formula ##STR1## in which R represents a C5 -C14 n-alkyl radical in the form of...
02/09/1982
4292327Method for treatment of human eye disease
Sterile aqueous humor from patients afflicted with the disease endogenous uveitis contains a previously unreported pathogenic microorganism, Micromyces intracellularis, which also has been found in tissue specimens from other diseases. When inoculated int...
09/29/1981
4196217Hydroxylated amines with bacteriostatic activity
The invention relates to new chemical compounds and to processes for their preparation. The compounds according to the invention correspond to the formula in which R is a saturated or unsaturated straight-chain C5 to C18 aliphatic radical...
04/01/1980
409235611,12-Secoprostaglandins
This invention relates to 11,12-secoprostaglandins and processes for their manufacture. These compounds have prostaglandin-like biological activity and are particularly useful as renal vasodilators, for the treatment of hypertension, for the prevention of...
05/30/1978
4048325Low toxicity method of inhibiting sickling of sickle erythrocytes
A low toxicity method of inhibiting sickling of sickle erythrocytes which comprises intermixing the erythrocytes with an effective anti-sickling amount of a water-soluble imidoester of the formula RC(=NH)OR' wherein R is an alkyl group of 1 - 8 carbon ato...
09/13/1977
 
Sign InRegister
Username  
Password   
forgot password?